Literature DB >> 9498059

Intracerebral hemorrhage in two patients with Down's syndrome and cerebral amyloid angiopathy.

J E Donahue1, J S Khurana, L S Adelman.   

Abstract

Cerebral amyloid angiopathy (CAA) is an important cause of spontaneous intracerebral hemorrhages in the elderly and is often seen in the brains of patients with Alzheimer's disease, Down's syndrome (DS), and hereditary cerebral hemorrhage with amyloidosis of the Dutch type. We report two patients with DS and extensive CAA who died of intracerebral hemorrhage; only two other such case reports exist in the literature. We believe the incidence of such cases is higher than is reported and that the likelihood of hemorrhage in the setting of CAA is independent of the patient's underlying disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9498059     DOI: 10.1007/s004010050789

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN: 0001-6322            Impact factor:   17.088


  18 in total

1.  Unilateral a(1) and m(1) occlusions in a child with trisomy 21.

Authors:  P Corr; P Lasjaunias
Journal:  Interv Neuroradiol       Date:  2001-10-15       Impact factor: 1.610

Review 2.  Cerebrovascular contributions to aging and Alzheimer's disease in Down syndrome.

Authors:  Donna M Wilcock; Frederick A Schmitt; Elizabeth Head
Journal:  Biochim Biophys Acta       Date:  2015-11-26

3.  Recurrent cerebral embolism in a young adult with Down's syndrome. A case report.

Authors:  Shimon Ishida; Masamichi Date; Yoshimitsu Doi; Toshihiko Sato; Masakazu Sugino; Fumiharu Kimura; Toshiaki Hanafusa
Journal:  J Neurol       Date:  2004-10       Impact factor: 4.849

4.  Mutation in the 3'untranslated region of APP as a genetic determinant of cerebral amyloid angiopathy.

Authors:  Gaël Nicolas; David Wallon; Claudia Goupil; Anne-Claire Richard; Cyril Pottier; Véronique Dorval; Mariana Sarov-Rivière; Florence Riant; Dominique Hervé; Philippe Amouyel; Maelenn Guerchet; Bebene Ndamba-Bandzouzi; Pascal Mbelesso; Jean-François Dartigues; Jean-Charles Lambert; Pierre-Marie Preux; Thierry Frebourg; Dominique Campion; Didier Hannequin; Elisabeth Tournier-Lasserve; Sébastien S Hébert; Anne Rovelet-Lecrux
Journal:  Eur J Hum Genet       Date:  2015-04-01       Impact factor: 4.246

Review 5.  Neuropathological correlates of amyloid PET imaging in Down syndrome.

Authors:  Eric E Abrahamson; Elizabeth Head; Ira T Lott; Benjamin L Handen; Elliott J Mufson; Bradley T Christian; William E Klunk; Milos D Ikonomovic
Journal:  Dev Neurobiol       Date:  2019-08-17       Impact factor: 3.964

Review 6.  Down syndrome, beta-amyloid and neuroimaging.

Authors:  Elizabeth Head; Alex M Helman; David Powell; Frederick A Schmitt
Journal:  Free Radic Biol Med       Date:  2017-09-19       Impact factor: 7.376

7.  Microbleeds and Cerebral Amyloid Angiopathy in the Brains of People with Down Syndrome with Alzheimer's Disease.

Authors:  Alex M Helman; Morgan Siever; Katie L McCarty; Ira T Lott; Eric Doran; Erin L Abner; Frederick A Schmitt; Elizabeth Head
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

Review 8.  Aging in Down Syndrome and the Development of Alzheimer's Disease Neuropathology.

Authors:  Elizabeth Head; Ira T Lott; Donna M Wilcock; Cynthia A Lemere
Journal:  Curr Alzheimer Res       Date:  2016       Impact factor: 3.498

9.  AbetaPP/APLP2 family of Kunitz serine proteinase inhibitors regulate cerebral thrombosis.

Authors:  Feng Xu; Mary Lou Previti; Marvin T Nieman; Judianne Davis; Alvin H Schmaier; William E Van Nostrand
Journal:  J Neurosci       Date:  2009-04-29       Impact factor: 6.167

Review 10.  A genetic cause of Alzheimer disease: mechanistic insights from Down syndrome.

Authors:  Frances K Wiseman; Tamara Al-Janabi; John Hardy; Annette Karmiloff-Smith; Dean Nizetic; Victor L J Tybulewicz; Elizabeth M C Fisher; André Strydom
Journal:  Nat Rev Neurosci       Date:  2015-08-05       Impact factor: 34.870

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.